TGS’ presentation for the Pareto Securities Energy Conference 2025 is available on www.newsweb.no or TGS’ website www.tgs.com. CEO Kristian Johansen will present today at 15:55 CEST. For more information, visit TGS.com or contact: Bård Stenberg VP IR & Communication Mobile: +47 992 45 235 investor@tgs.com Attachment Pareto Securities Energy Conference 2025 ...

公司合规与上市状态 - 法拉第未来已完全满足纳斯达克一年合规监测期内的所有要求 并通过审查 恢复完全正常上市公司地位 [1][11] - 公司坚持"不进一步反向拆股"和审慎股权发行的原则 致力于保护股东利益 [9] 管理层股票购买行为 - 创始人兼全球联席CEO YT Jia在过去一个月内依据10b5-1计划完成第三次股票购买 总额约56万美元 [2] - 具体购买记录包括：9月8日购买约18万美元（含交易佣金） 9月2日购买约18万美元 8月25日购买约20万美元 [3] - 这些购买行为代表其120万美元签约奖金的税后部分全部投入公司股票 [4] - YT Jia表示此举体现对其长期战略的充分信心 旨在与股东共同实现价值最大化 [5] 战略与业务进展 - 成功推出第二品牌Faraday X（FX）及全球汽车行业桥梁战略 [9] - 8月发布"双飞轮&双桥梁"生态战略 [9] - FX战略旨在推出配备FF 91同级豪华技术的大规模生产车型 面向中低价位更广阔市场 [6] 组织与运营优化 - 创始团队回归 YT Jia晋升联席CEO并推出"十连击"组合措施 [9] - 业务基础和资本基础实现质的突破 [9] - 通过加强成本控制和现金流管理 显著提升财务运营效率 [9] 资本与融资情况 - 成功完成多笔融资交易 预计支持FX Super One的初始生产和交付 [9] - 加速其他FF和FX产品及AI相关技术的开发与交付进程 [9] 公司背景与定位 - 加州全球共享智能电动出行生态系统公司 2014年成立 [6] - 使命是通过以用户为中心、技术驱动的智能驾驶体验颠覆汽车行业 [6] - 旗舰车型FF 91体现豪华、创新和性能愿景 [6]

项目概述 - BHP Xplor加速器项目正式开放2026届申请 旨在变革关键矿产勘探 为期九个月 [1] - 项目面向初级勘探公司 寻求雄心勃勃的团体和人才 致力于发掘关键矿产新来源 [1] - 项目已成功举办2023、2024和2025届 目前参与者网络涵盖21家公司 [1] 资源支持 - 提供最高50万美元非股权资金 专家指导 以及BHP全球供应商网络接入权限 [1] - 通过专业知识输送和网络资源加速勘探公司发展轨迹 [1] - 参与者可获得跨地域和不同地质概念的勘探项目多元管道支持 [2] 战略价值 - 项目强化参与者勘探机会 促进与BHP建立长期合作关系 [1] - 为大型矿企与初级勘探公司建立强有力合作伙伴关系 应对全球关键矿产需求增长 [1] - 当前参与者评价项目"无价" 对发展战略和项目推进产生切实影响 [2] 时间安排 - 2026届申请期为2025年9月8日至10月15日 [2] - 项目持续九个月 采用加速器模式运作 [1]

NEW YORK and WALTHAM, Mass., Sept. 09, 2025 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to advancing the next generation of antibody complement therapeutics to treat severe autoimmune diseases (“Dianthus” or the “Company”), today announced the pricing of its previously announced upsized underwritten public offering of 6,487,879 shares of its common stock at a public offering price per share of $33.00 and, in lieu of common stock to certain ...

SOMPO uses Radar to accelerate data-driven management across pricing, underwriting and portfolio optimization, and with Sompo Direct Insurance Inc. implementing Radar as its rate calculation engine.TOKYO, Sept. 09, 2025 (GLOBE NEWSWIRE) -- WTW (NASDAQ: WTW), a leading global advisory, broking and solutions company, and Sompo Holdings, Inc., one of Japan’s leading insurance groups, today announced a global partnership to deploy WTW’s Radar technology across SOMPO Group. This marks the first global agreement ...

VANCOUVER, British Columbia, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Prime Mining Corp. (“Prime” or the “Company”) (TSX: PRYM) (OTCQX: PRMNF) (Frankfurt: O4V3) announced today that it has filed its notice of meeting and management information circular (the “Circular”) with securities regulators in connection with the special meeting (the “Meeting”) of the holders (the “Shareholders”) of common shares of the Company (the “Prime Shares”), the holders (the “Option Holders”) of options to purchase Prime Shares (the ...

BOSTON and SAN DIEGO, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Rapport Therapeutics, Inc. (Nasdaq: RAPP) (“Rapport” or the “Company”), a clinical-stage biotechnology company dedicated to the discovery and development of small molecule precision medicines for patients with neurological or psychiatric disorders, today announced the pricing of an underwritten public offering of 9,615,385 shares of its common stock at a public offering price of $26.00 per share. All of the shares in the offering are being sold by Rap ...

New York, NY, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Trailblazer Acquisition Corp. (the “Company”) announced today the pricing of its upsized initial public offering of 24,000,000 units at a price of $10.00 per unit. The units are expected to be listed on The Nasdaq Global Stock Market LLC (“Nasdaq”) and begin trading on September 10, 2025, under the ticker symbol “BLZRU.” Each unit consists of one Class A ordinary share and one-third of one redeemable warrant, each whole warrant entitling the holder thereof t ...

MELBOURNE, Australia and INDIANAPOLIS, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces it has dosed the first patient in a Phase 3 clinical trial aimed at expanding the indications for Illuccix® and Gozellix® (kits for the preparation of gallium-68 (68Ga) gozetotide injection) to include prostate cancer diagnosis. BiPASS™ (Biopsy of the Prostate Avoidance Stratification Study1) is the first registration-enabling study to evaluate whether the ...

St. Petersburg, Fla., Sept. 09, 2025 (GLOBE NEWSWIRE) -- Raymond James Financial, Inc. (NYSE: RJF) (“Raymond James” or the “Company”) today announced the pricing of a registered underwritten public offering of (i) $650,000,000 aggregate principal amount of 4.900% senior notes due 2035 (the “2035 Notes”) and (ii) $850,000,000 aggregate principal amount of 5.650% senior notes due 2055 (the “2055 Notes” and, together with the 2035 Notes, the “Notes”). The 2035 Notes will bear interest at a rate of 4.900% per a ...